Welcome to Elekta’s Capital Markets Day in Stockholm on September 27, 2018

STOCKHOLM, July 5, 2018 – Elekta (EKTA-B.ST) invites equity analysts, investors and media representatives to Elekta’s Capital Markets Day on September 27 at Stockholm Waterfront Congress Centre. A light lunch will be provided from 12:00. Presentations will start at 13:00 CET and will end at approximately 16:30 CET.

Speakers at the event will include Dr. Richard Hausmann, President and CEO, Gustaf Salford, CFO, and other members of Elekta’s management team.

To attend, please register through the following link: http://www.cvent.com/d/5gq38r no later than August 31, 2018.

It will also be possible to follow the Capital Markets Day over the phone or as a live webcast.

Live webcast: http://elekta-live.creo.tv/180927/cmd-2018

To take part over the phone, please dial in about 5-10 minutes in advance. 

  • Sweden: +46 8 566 426 91
  • UK: +44 203 0089 803
  • U.S.: +1 855 831 5946

We look forward to your participation.

# # #

For further information, please contact:
Oskar Bosson, Global EVP Corporate Communications and Investor Relations
Tel: +46 70 410 7180, e-mail: Oskar.Bosson@elekta.com
Time zone: CET: Central European Time

Johan Andersson, Director Investor Relations
Tel: +46 702 100 451, e-mail: johan.andersson@elekta.com
 

About Elekta
Elekta is proud to be the leading innovator of equipment and software used to improve, prolong and save the lives of people with cancer and brain disorders. Our advanced, effective solutions are created in collaboration with customers, and more than 6,000 hospitals worldwide rely on Elekta technology. Our treatment solutions and oncology informatics portfolios are designed to enhance the delivery of radiation therapy, radiosurgery and brachytherapy, and to drive cost efficiency in clinical workflows. Elekta employs 3,700 people around the world. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm. www.elekta.com.

Tags:

About Us

Elekta is proud to be the leading innovator of equipment and software used to improve, prolong and save the lives of people with cancer and brain disorders. Our advanced, effective solutions are created in collaboration with customers, and more than 6,000 hospitals worldwide rely on Elekta technology. Our treatment solutions and oncology informatics portfolios are designed to enhance the delivery of radiation therapy, radiosurgery and brachytherapy, and to drive cost efficiency in clinical workflows. Elekta employs 3,600 people around the world. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm. www.elekta.com

Subscribe

Documents & Links